Company intelligence / Profile preview

Chuanghui Biotechnology

Xi'an, Shaanxi, China

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Chuanghui Biotechnology is a Chinese biotechnology company focused on the development and commercialization of recombinant humanized collagen products. Utilizing synthetic biology and advanced fermentation techniques, the company produces high-purity collagen for medical aesthetics, dermatology, and wound management. Their portfolio includes Class II and Class III medical devices such as collagen dressings, gels, and sprays designed for skin repair and post-operative recovery. Chuanghui is a significant player in the industrialization of recombinant collagen, maintaining large-scale manufacturing facilities in Xi'an.

Therapeutic areas: Dermatology
Modalities: Recombinant proteinBiologic
Industry: Biotech

Drug pipeline

1 asset

CH3127

Unknown

Beyond the preview

Go deeper on Chuanghui Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chuanghui Biotechnology.

Explore the full profile